UBS Maintains Neutral on Viavi Solutions, Lowers Price Target to $33
Benzinga Newsdesk 12 hours ago
Analyst RatingsNewsPrice Target
UBS analyst Andrew Spinola maintains Viavi Solutions (NASDAQ:VIAV) with a Neutral and lowers the price target from $44 to $33.
UBS analyst Andrew Spinola maintains Viavi Solutions (NASDAQ:VIAV) with a Neutral and lowers the price target from $44 to $33.